In addition, as challenges still existed in diagnosing the HFpEF in the setting of patients with obesity for a variety of reasons, including lower NT-proBNP levels, and the overlap of symptoms,5 our study possibly provided new noninvasive GLS and eGLSR parameters. This evidence concerns the gene NPPB and obesity due to melanocortin 4 receptor deficiency.